Fresenius Medical Care AG & Co. KGaA
FMSNYSEHealthcare● Active
$22.03
$-0.01(-0.02%)
Market Cap$11.8B
P/E Ratio—
52W High$29.07
52W Low$20.02
Fresenius Medical Care AG & Co. KGaA (FMS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · FMS · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $19.63B | $19.34B | $19.45B | $19.40B | $17.62B |
| Cost of Revenue | $14.60B | $14.58B | $14.53B | $14.50B | $12.85B |
| Gross Profit | $5.03B | $4.76B | $4.93B | $4.89B | $4.77B |
| Gross Margin %(computed) | 25.62% | 24.60% | 25.32% | 25.23% | 27.09% |
| Operating Expenses | |||||
| R&D Expenses | $0.16B | $0.18B | $0.23B | $0.23B | $0.22B |
| G&A Expenses | $2.41B | $2.48B | $2.49B | $2.37B | $0.00B |
| Total Operating Expenses | $3.20B | $3.29B | $3.56B | $3.38B | $2.92B |
| Operating Income | $1.83B | $1.47B | $1.37B | $1.51B | $1.85B |
| Operating Margin %(computed) | 9.31% | 7.59% | 7.04% | 7.79% | 10.51% |
| Interest Income | $0.07B | $0.07B | $0.09B | $0.07B | $0.07B |
| Interest Expense | $0.38B | $0.41B | $0.42B | $0.36B | $0.35B |
| Income Before Tax | $1.51B | $1.06B | $1.03B | $1.22B | $1.57B |
| Income Tax Expense | $0.32B | $0.32B | $0.30B | $0.32B | $0.35B |
| Net Income | $0.98B | $0.54B | $0.50B | $0.67B | $0.97B |
| Net Margin %(computed) | 4.98% | 2.78% | 2.57% | 3.47% | 5.50% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.68 | $0.92 | $0.85 | $0.57 | $0.83 |
| Wtd Avg Shares | 0.58B | 0.59B | 0.59B | 1.17B | 1.17B |
| EBITDA | $3.40B | $3.21B | $3.21B | $3.42B | $3.55B |
| EBITDA Margin %(computed) | 17.31% | 16.58% | 16.50% | 17.62% | 20.14% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · EUR · B
Explore more Fresenius Medical Care AG & Co. KGaA data
About Fresenius Medical Care AG & Co. KGaA (FMS) Income Statement
Fresenius Medical Care AG & Co. KGaA (FMS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, FMS reported revenue of $19.63B, gross profit of $5.03B (gross margin 25.62%), and net income of $0.98B — a net profit margin of 4.98%.
Frequently asked questions
FMS · 4 questionsFresenius Medical Care AG & Co. KGaA (FMS) reported revenue of $19.63B for 2025, up 1.5% year-over-year.
FMS revenueFMS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08